This company listing is no longer active
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Acerus Pharmaceuticals 관리
관리 기준 확인 2/4
주요 정보
Ed Gudaitis
최고 경영자
US$807.1k
총 보상
| CEO 급여 비율 | 24.7% |
| CEO 임기 | 4.8yrs |
| CEO 소유권 | 1.0% |
| 경영진 평균 재임 기간 | 3.8yrs |
| 이사회 평균 재임 기간 | 6yrs |
최근 관리 업데이트
Have Insiders Been Buying Acerus Pharmaceuticals Corporation (TSE:ASP) Shares?
Mar 12
The Independent Director of Acerus Pharmaceuticals Corporation (TSE:ASP), Stephen Gregory, Just Bought 52% More Shares
Nov 30
Recent updates
Auditors Have Doubts About Acerus Pharmaceuticals (TSE:ASP)
Mar 14Have Insiders Been Buying Acerus Pharmaceuticals Corporation (TSE:ASP) Shares?
Mar 12Acerus Pharmaceuticals' (TSE:ASP) Shareholders Are Down 88% On Their Shares
Jan 22The Independent Director of Acerus Pharmaceuticals Corporation (TSE:ASP), Stephen Gregory, Just Bought 52% More Shares
Nov 30CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -US$28m |
| Jun 30 2022 | n/a | n/a | -US$29m |
| Mar 31 2022 | n/a | n/a | -US$28m |
| Dec 31 2021 | US$807k | US$199k | -US$34m |
| Sep 30 2021 | n/a | n/a | -US$32m |
| Jun 30 2021 | n/a | n/a | -US$34m |
| Mar 31 2021 | n/a | n/a | -US$33m |
| Dec 31 2020 | US$664k | US$177k | -US$24m |
| Sep 30 2020 | n/a | n/a | -US$21m |
| Jun 30 2020 | n/a | n/a | -US$19m |
| Mar 31 2020 | n/a | n/a | -US$16m |
| Dec 31 2019 | US$190k | US$181k | -US$16m |
| Sep 30 2019 | n/a | n/a | -US$17m |
| Jun 30 2019 | n/a | n/a | -US$16m |
| Mar 31 2019 | n/a | n/a | -US$19m |
| Dec 31 2018 | US$394k | US$185k | -US$19m |
보상 대 시장: Ed's total compensation ($USD807.09K) is above average for companies of similar size in the Canadian market ($USD172.94K).
보상과 수익: Ed's compensation has increased whilst the company is unprofitable.
CEO
Ed Gudaitis
4.8yrs
테뉴어
US$807,086
보상
Mr. Edward Gudaitis, also known as Ed, is President, Director and Chief Executive Officer at Acerus Pharmaceuticals Corp. since May 01, 2018. He is a Director for BioteCanada. Mr. Gudaitis has spent many y...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 4.8yrs | US$807.09k | 1.03% $ 28.6k | |
| Senior Vice President of International Commercial | 3.8yrs | US$411.98k | 데이터 없음 | |
| Chief Medical Officer | 2.7yrs | US$452.01k | 데이터 없음 | |
| Interim Chief Financial Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Senior VP | 6.7yrs | US$287.97k | 0.0046% $ 128.8 | |
| President of Acerus Pharmaceuticals SRL | no data | US$306.94k | 데이터 없음 |
3.8yrs
평균 재임 기간
경험이 풍부한 관리: ASP's management team is considered experienced (3.8 years average tenure).
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 4.8yrs | US$807.09k | 1.03% $ 28.6k | |
| Vice Chairman | less than a year | 데이터 없음 | 0.032% $ 899.9 | |
| Chairman of the Board | 9.5yrs | US$46.15k | 데이터 없음 | |
| Independent Director | 11.7yrs | US$38.12k | 데이터 없음 | |
| Lead Independent Director | 7.3yrs | US$32.11k | 0.032% $ 877.4 | |
| Independent Director | 2.8yrs | US$44.01k | 데이터 없음 |
6.0yrs
평균 재임 기간
69yo
평균 연령
경험이 풍부한 이사회: ASP's board of directors are considered experienced (6 years average tenure).